Register
Login:
Share:
Email Facebook Twitter

Add Provexis to quick picks

Provexis Share Price (PXS)



Share Price Information for Provexis (PXS)


Share Price: 0.73Bid: 0.70Ask: 0.76Change: -0.025 (-3.31%)Faller - Provexis
Spread: 0.06Spread as %: 8.57%Open: 0.70High: 0.75Low: 0.70Yesterday’s Close: 0.755

Provexis Plc Ord 0.1P

Provexis is listed in the FTSE AIM All-Share
Provexis is part of the Food Producers sector




Intraday Provexis Share Chart


Intraday Provexis Share Price Chart


Share Price SpacerPrice
0.73

Share Price SpacerBid
0.70

Share Price SpacerAsk
0.76

Share Price SpacerChange
-3.31%-0.025

Share Price SpacerVolume
2,758,575

Share Price SpacerOpen
0.70

Share Price SpacerHigh
0.75

Share Price SpacerLow
0.70

Share Price SpacerClose
0.755

Share Price SpacerCurrency
GBX

3 Month Provexis Share Graph


3 Month Provexis Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 1,561.82m £11.40m 300,000

52 Week High 2.10 52 Week High Date 18-NOV-2013
52 Week Low 0.57 52 Week Low Date 8-MAY-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
12 1,908,575 850,000 -2.517 -0.29 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Aug-14
15:42:29
0.727
170,000
Sell* 
0.71
0.79
1,236
Trade Type:
Ordinary

21-Aug-14
14:30:44
0.727
8,575
Sell* 
0.71
0.79
62.34
Trade Type:
Ordinary

21-Aug-14
09:14:49
0.7218
250,000
Sell* 
0.71
0.79
1,805
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Provexis trades >>

Directors Deals for Provexis (PXS)
Trade DateActionNotifierPriceCurrencyAmountHolding
31-Mar-13Notification of Holding
Trade Notifier Information for Provexis
Stephen Moon held the position of CEO at Provexis at the time of this trade.
 Stephen Moon
000
31-Mar-13Notification of Holding
Trade Notifier Information for Provexis
Ian Ford held the position of Finance Director at Provexis at the time of this trade.
 Ian Ford
000
31-Mar-13Notification of Holding
Trade Notifier Information for Provexis
Dawson Buck held the position of Non-Executive Chairman at Provexis at the time of this trade.
 Dawson Buck
000
View more Provexis directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Today 18:17
redprince
jonesy
0.73
No Opinion

From my understanding of the agreement we have not covered our share of the start up costs -DSM have completed the initial scale up costs of production but that does not mean we are not drawing down a continued share of same from our share of profits.
Today 17:58
pumpky
redprince
0.73
No Opinion

Agreed,the next set of results will be interesting,and should reveal all,the only thing in that statement that sticks out was" Initial start up costs of the powder,more costs to come?No one knows how much Dsm are selling and what is the profit split,hopefully meet at the Agm(wherever it is)
Today 17:53
jonesy229
rns
0.73
No Opinion

this is far mor positive than i was expecting they have covered set up costs which they stated were substacial so must be generating a good revenue
Today 17:48
redprince
RNS part 2
0.73
No Opinion

if raised, would be sufficient to enable Provexis to meet its working capital requirements." However to finish on a positive note "An increasing number of further commercial projects have been initiated by DSM with prospective customers, with good prospects for these projects to be launched as consumer products. Interest in the technology exists in all major global markets." The next set of interims should be interesting!
Today 17:45
redprince
RNS
0.73
No Opinion

It is indeed welcome news that revenues albeit modest ones have restarted.Further good news was hinted at in this sentence "The initial powder manufacturing setup phase for Fruitflow® has now been concluded, and a reduction in Fruitflow® powder production costs was realised towards the close of the quarter ended 30 June 2014." It is reasonable to assume that whilst our contribution to set up costs which has been amortised and will continue to be deducted from out bottom line for the foreseeable,any increase in revenues from new or existing sales of FF will add to our share going forward.There will also be an increased % share at some point when the various performance milestones (as mentioned in the terms of the AA) are met. However we have limited cash and associated with that are various risks which the FD has detailed in the rns: Quote "Principal risks and uncertainties In the course of its normal business the Group is exposed to a range of risks and uncertainties which could impact on the results of the Group. The Board considers that risk-management is an integral part of good business process and, on a bi-annual basis, reviews the industry, operational and financial risks facing the Group and considers the adequacy of the controls and mitigants to manage the risks. The directors have identified the following principal risks and uncertainties that could have the most significant impact on the Group's long-term value generation. Funding and other risks Provexis has experienced operating losses from continuing operations in each year since its inception. Accordingly until Provexis has sufficient commercial success with Fruitflow® to be cash generative it will continue to rely on its existing cash resources and further funding rounds to continue its activities. While Provexis aims to generate licensing revenues from Fruitflow®, there is no certainty that such revenues will be generated. Furthermore, the amount and timing of revenues from Fruitflow® is uncertain and will depend on numerous factors, most of which are outside Provexis' control due to the terms of the Alliance Agreement. It is therefore difficult for the directors to predict with accuracy the timing and amount of any further capital that may be required by the Provexis Group." Factors that could increase Provexis' funding requirements include, but are not limited to: higher operational costs; slower progress than expected in DSM attracting customers to purchase Fruitflow®; unexpected opportunities to develop additional products or acquire additional technologies, products or businesses; and costs incurred in relation to the protection of Provexis' intellectual property. Any additional share issues may have a dilutive effect on Provexis Shareholders. Further, there can be no guarantee or assurance that additional equity funding will be forthcoming when required, nor as to the terms a
Today 17:41
alfista
RE: Crohn's
0.73
No Opinion

Worth what someone would pay, and it doesn't look like anyone is bashing their doors down to get it. I wonder if it may be revived once Fruitflow revenues could support that? Selfishly I hope not, but on the other hand, if a treatment for that horrible illness can be developed.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Provexis (PXS) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs




Sign up for Live Prices


CD02WL.001.081313
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.